,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,301,28,0.0930232558139535,285,70,0.245614035087719,-0.152590779273766,0.077124796450926,0.231500824656125,-0.154376028205199
training,middle 30%,233,5,0.0214592274678112,269,12,0.0446096654275093,-0.0231504379596981,0.0434280639043462,0.0708795287486973,-0.0274514648443511
training,highest 35%,317,67,0.211356466876972,269,32,0.118959107806691,0.0923973590702802,0.21444760363796,0.0982420696542309,0.116205533983729
test,lowest 50%,409,51,0.124694376528117,428,59,0.13785046728972,-0.0131560907616022,0.0637966017846971,0.181993952360623,-0.118197350575925
test,highest 50%,414,46,0.111111111111111,423,58,0.137115839243499,-0.0260047281323877,0.161951561786571,0.0861400458400737,0.0758115159464976
